Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia [1]

Blood

Volumn 99, Issue 2, 2002, Pages 722-723

  Anether, Gabriele ^a   Marschitz, Ingrid ^a   Tinhofer, Inge ^a   Greil, Richard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CYTOKINE; INTERLEUKIN 15;

ANTIGEN EXPRESSION; APOPTOSIS; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; LETTER; NATURAL KILLER CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0037079721     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.722     Document Type: Letter

References (6)

1. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia
2. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia
3. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders
4. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies
5. Mechanism and biological significance of CD4-mediated cytotoxicity
6. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-CD95) ligand+ tumor cells in B chronic lymphocytic leukemia